Completed OBSERVATIONAL NCT02746445

A Longitudinal Study on the Safety and Efficacy for Subjects With ASD Who Received MeRT

A Longitudinal Study on the Safety and Efficacy for Subjects With Autism Spectrum Disorder (ASD) Who Received Magnetic EEG/ECG-Guided Resonance Therapy (MeRT)

Sponsor: Wave Neuroscience

Conditions Autistic Disorder

Interventions No intervention

Updated 8 times since 2017 Last updated: May 5, 2017 Started: Apr 30, 2016 Primary completion: Apr 30, 2017 Completion: Apr 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02746445, this observational or N/A phase trial focuses on Autistic Disorder and remains completed. Sponsored by Wave Neuroscience, it has been updated 8 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Oct 2019 — Jan 2021 [monthly]

Completed
Jun 2018 — Oct 2019 [monthly]

Completed

▶ Show 3 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jul 2017 — Apr 2018 [monthly]

Completed NA

Status: Enrolling By Invitation → Completed
Jan 2017 — Jul 2017 [monthly]

Enrolling By Invitation NA

First recorded

Apr 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Wave Neuroscience

Data source: Wave Neuroscience

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Newport Beach, United States